A Curve‐Free Method for Phase I Clinical Trials (Q4667490)

From MaRDI portal
Revision as of 08:59, 30 July 2024 by Openalex240730090724 (talk | contribs) (Set OpenAlex properties.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article; zbMATH DE number 2159529
Language Label Description Also known as
English
A Curve‐Free Method for Phase I Clinical Trials
scientific article; zbMATH DE number 2159529

    Statements

    A Curve‐Free Method for Phase I Clinical Trials (English)
    0 references
    0 references
    0 references
    0 references
    20 April 2005
    0 references
    continual reassessment method
    0 references
    dose-finding studies
    0 references
    maximum tolerated dose
    0 references
    neutral to the right process
    0 references
    phase I clinical trial
    0 references
    product-of-beta priors
    0 references
    toxicity
    0 references

    Identifiers